These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12404258)

  • 1. Discussion on 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.
    Kamiński R; Kozar K; Kopeć M; Basak G; Skierski JS; Koronkiewicz M; Jakóbisiak M; Gołab J
    Gastroenterology; 2002 Nov; 123(5):1747; author reply 1747-8. PubMed ID: 12404258
    [No Abstract]   [Full Text] [Related]  

  • 2. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Inoue M; Nakamura H
    Gastroenterology; 2002 Feb; 122(2):308-17. PubMed ID: 11832446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
    Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase inhibitor, pravastatin on liver metastasis of a pancreatic cancer cell line, SUIT-2 in nude mice].
    Shimazoe T; Kono A; Funakoshi A
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1077-9. PubMed ID: 8002625
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
    Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
    Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitors for the treatment of pancreatic cancer.
    Schmid RM
    Gastroenterology; 2002 Feb; 122(2):565-7. PubMed ID: 11832469
    [No Abstract]   [Full Text] [Related]  

  • 7. Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas.
    Wei JT; Mott LA; Baron JA; Sandler RS;
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1026-7. PubMed ID: 15824186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and the risk of pancreatic cancer in Type 2 diabetic patients: Immortal time bias in survival analysis?
    Hu YW
    Int J Cancer; 2016 Jul; 139(1):232. PubMed ID: 26918933
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of statins in cancer therapy.
    Hindler K; Cleeland CS; Rivera E; Collard CD
    Oncologist; 2006 Mar; 11(3):306-15. PubMed ID: 16549815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
    Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC
    EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falls and 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
    Pasco JA; Kotowicz MA; Henry MJ; Sanders KM; Nicholson GC
    Arch Intern Med; 2002 Nov; 162(20):2381. PubMed ID: 12418958
    [No Abstract]   [Full Text] [Related]  

  • 12. Regarding "3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy".
    Kok NF; Koppert LB
    J Vasc Surg; 2006 Mar; 43(3):643-4; author reply 644. PubMed ID: 16520193
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Adam O; Neuberger HR; Böhm M; Laufs U
    Circulation; 2008 Sep; 118(12):1285-93. PubMed ID: 18794401
    [No Abstract]   [Full Text] [Related]  

  • 14. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
    Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
    Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isopentenoid synthesis in eukaryotic cells. An initiating role for post-translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Giron MD; Havel CM; Watson JA
    Arch Biochem Biophys; 1993 Apr; 302(1):265-71. PubMed ID: 8097083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.
    Blum A; Simsolo C; Hasin Y
    Atherosclerosis; 2004 Jul; 175(1):1-5. PubMed ID: 15186940
    [No Abstract]   [Full Text] [Related]  

  • 17. Does 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy exert a direct anti-ischemic effect?
    Di Napoli P; Barsotti A
    Circulation; 1998 Mar; 97(9):937. PubMed ID: 9521345
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing metastatic emergence of breast cancer.
    Wells A; Beckwitt C; Marti JLG
    Aging (Albany NY); 2021 Oct; 13(19):22627-22628. PubMed ID: 34633294
    [No Abstract]   [Full Text] [Related]  

  • 19. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.
    Glynn SA; O'Sullivan D; Eustace AJ; Clynes M; O'Donovan N
    BMC Cancer; 2008 Jan; 8():9. PubMed ID: 18199328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Turkoski BB
    Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.